FDA Drug Surveillance Could Be Enhanced Through Inter-Agency Collaboration
This article was originally published in The Tan Sheet
FDA should strengthen its ties to other government agencies in order to gain access to data for population-based studies on drug safety, members of the Drug Safety & Risk Management Advisory Committee suggested at a May 18-19 meeting
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC